Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹2.09 Cr₹4,561 Cr₹-528 Cr₹-333 Cr₹-675 Cr

What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS is ₹2.09 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹2.09 Cr
Mar2024₹4,561 Cr
Mar2023₹-528 Cr
Mar2022₹-333 Cr
Mar2021₹-675 Cr

How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹2.09 Cr
-99.95
Mar2024 ₹4,561 Cr
Positive
Mar2023 ₹-528 Cr
Negative
Mar2022 ₹-333 Cr
Negative
Mar2021 ₹-675 Cr -

Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,435.7 Cr 3.9% 3.6% 63.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.9%

3.6%

63.4%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses